- Home
- ADAG vs WW Comparison
ADAG vs WW Comparison
Compare ADAG & WW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAG
- WW
- Stock Information
- Founded
- ADAG 2011
- WW 1961
- Country
- ADAG China
- WW United States
- Employees
- ADAG N/A
- WW N/A
- Industry
- ADAG Biotechnology: Pharmaceutical Preparations
- WW Other Consumer Services
- Sector
- ADAG Health Care
- WW Consumer Discretionary
- Exchange
- ADAG Nasdaq
- WW Nasdaq
- Market Cap
- ADAG 81.9M
- WW 75.9M
- IPO Year
- ADAG 2021
- WW 2001
- Fundamental
- Price
- ADAG $1.42
- WW $0.40
- Analyst Decision
- ADAG Strong Buy
- WW Buy
- Analyst Count
- ADAG 1
- WW 4
- Target Price
- ADAG $8.00
- WW $3.44
- AVG Volume (30 Days)
- ADAG 29.9K
- WW 15.7M
- Earning Date
- ADAG 03-24-2025
- WW 05-05-2025
- Dividend Yield
- ADAG N/A
- WW N/A
- EPS Growth
- ADAG N/A
- WW N/A
- EPS
- ADAG N/A
- WW N/A
- Revenue
- ADAG $103,204.00
- WW $785,921,000.00
- Revenue This Year
- ADAG $6,488.89
- WW N/A
- Revenue Next Year
- ADAG $57.50
- WW N/A
- P/E Ratio
- ADAG N/A
- WW N/A
- Revenue Growth
- ADAG N/A
- WW N/A
- 52 Week Low
- ADAG $1.33
- WW $0.12
- 52 Week High
- ADAG $3.58
- WW $2.35
- Technical
- Relative Strength Index (RSI)
- ADAG 39.32
- WW 54.09
- Support Level
- ADAG $1.36
- WW $0.12
- Resistance Level
- ADAG $1.92
- WW $0.16
- Average True Range (ATR)
- ADAG 0.13
- WW 0.07
- MACD
- ADAG -0.00
- WW 0.01
- Stochastic Oscillator
- ADAG 13.79
- WW 67.22
About ADAG Adagene Inc.
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.
About WW WW International Inc.
WW International Inc is a provider of weight loss solutions. The firm offers its members access to in person workshops and digital solutions as a part of its weight loss and weight management programs. Its digital app provides members access to tools such as, trackers for food, water, activity, weight, content regarding behavioral techniques for building healthy habits and other related tools. Along with its in person workshops and digital solutions, the company also provides members who medically qualify access to clinicians who can prescribe weight management medications when clinically appropriate. The company generates majority of its revenue in the form of Subscription Revenue. Geographically, the company generates key revenue from North America and rest from International markets.